Treatment of Streptococcus pyogenes Infections
Uncomplicated Pharyngitis: First-Line Treatment
Penicillin V or amoxicillin remains the drug of choice for Group A streptococcal pharyngitis due to proven efficacy, narrow spectrum, safety, low cost, and the absence of documented penicillin resistance worldwide. 1, 2
Recommended Regimens for Pharyngitis
Oral therapy:
- Penicillin V: 250 mg twice or three times daily for 10 days (children); 250 mg three to four times daily or 500 mg twice daily for 10 days (adults) 1
- Amoxicillin: 50 mg/kg once daily (maximum 1000 mg) or 25 mg/kg twice daily (maximum 500 mg per dose) for 10 days in children; 500 mg twice daily for 10 days in adults 2, 3
Intramuscular therapy (for patients unlikely to complete oral course):
- Benzathine penicillin G: 1.2 million units as a single dose 1
Critical Treatment Duration
A full 10-day course is mandatory for all antibiotics (except azithromycin) to achieve maximal pharyngeal eradication and prevent acute rheumatic fever. Shortening the course by even a few days results in appreciable increases in treatment failure rates and rheumatic fever risk. 2, 3
Treatment in Patients with Penicillin Allergy
Step 1: Determine the Type of Allergic Reaction
The type of penicillin allergy dictates which alternatives are safe:
- Immediate/anaphylactic reactions (anaphylaxis, angioedema, respiratory distress, urticaria within 1 hour): Up to 10% cross-reactivity with all beta-lactams, including cephalosporins—avoid all beta-lactam antibiotics 2, 3
- Non-immediate/delayed reactions (mild rash occurring >1 hour after exposure): Only 0.1% cross-reactivity with first-generation cephalosporins—first-generation cephalosporins are safe and preferred 2, 3
Step 2: Select Appropriate Antibiotic Based on Allergy Type
For non-immediate penicillin allergy:
- First-generation cephalosporins are the preferred alternative with strong, high-quality evidence 2, 3
- Cephalexin: 500 mg twice daily for 10 days (adults); 20 mg/kg per dose twice daily for 10 days (children, maximum 500 mg per dose) 2, 3
- Cefadroxil: 1 gram once daily for 10 days (adults); 30 mg/kg once daily for 10 days (children) 2
For immediate/anaphylactic penicillin allergy:
- Clindamycin is the preferred choice with strong, moderate-quality evidence and only ~1% resistance among U.S. Group A Streptococcus isolates 2, 3
- Clindamycin: 300 mg three times daily for 10 days (adults); 7 mg/kg per dose three times daily for 10 days (children, maximum 300 mg per dose) 2, 3
Alternative macrolides (less preferred due to resistance):
- Azithromycin: 500 mg once daily for 5 days (adults); 12 mg/kg once daily for 5 days (children, maximum 500 mg)—only antibiotic requiring just 5 days due to prolonged tissue half-life 2, 3
- Clarithromycin: 250 mg twice daily for 10 days (adults); 7.5 mg/kg per dose twice daily for 10 days (children, maximum 250 mg per dose) 2
- Macrolide resistance is 5-8% in the United States and varies geographically, making clindamycin more reliable when beta-lactams cannot be used 2, 3
Skin and Soft Tissue Infections (Impetigo/Ecthyma)
For impetigo or ecthyma caused by streptococci alone, oral penicillin is the recommended agent for a 7-day course. 1
When both Staphylococcus aureus and streptococci are suspected:
- Dicloxacillin or cephalexin for 7 days (for methicillin-susceptible S. aureus) 1
- When MRSA is suspected or confirmed: doxycycline, clindamycin, or trimethoprim-sulfamethoxazole for 7 days 1
Severe Invasive Infections
Necrotizing Fasciitis and Streptococcal Toxic Shock Syndrome
Combination therapy with clindamycin plus penicillin is the recommended regimen for necrotizing fasciitis and streptococcal toxic shock syndrome caused by Group A streptococci. 1
Recommended dosing:
Rationale: Clindamycin suppresses toxin production and modulates cytokine (TNF) production, with animal studies and observational data demonstrating superior efficacy versus penicillin alone. Penicillin is added because of increasing macrolide resistance, though clindamycin resistance in Group A streptococci remains <1% in the United States. 1, 2
Surgical Management
Immediate surgical debridement is critical for necrotizing infections. Antibiotic therapy alone is insufficient—early and aggressive surgical exploration with debridement of necrotic tissue is essential for survival. 1
Common Pitfalls and Critical Considerations
Do NOT:
- Prescribe cephalosporins to patients with immediate/anaphylactic penicillin reactions due to the ~10% cross-reactivity risk 2, 3
- Shorten antibiotic courses below 10 days (except azithromycin's 5-day regimen), as this markedly increases treatment failure and rheumatic fever risk 2, 3
- Use trimethoprim-sulfamethoxazole for streptococcal pharyngitis—sulfonamides fail to eradicate Group A Streptococcus in 20-25% of cases 2
- Prescribe broad-spectrum cephalosporins (cefuroxime, cefdinir, cefpodoxime) when narrow-spectrum first-generation agents are appropriate—they are more expensive and select for resistant flora 2
- Order routine post-treatment throat cultures for asymptomatic patients who completed therapy—reserve testing for special circumstances such as history of rheumatic fever 2
Chronic Carriers
Chronic pharyngeal carriers generally do not require antimicrobial therapy because they are unlikely to spread infection and are at very low risk for complications. 2
When treatment is indicated for chronic carriers (e.g., community outbreak of rheumatic fever, family history of rheumatic fever):
- Clindamycin demonstrates substantially higher eradication rates than penicillin or amoxicillin in eliminating chronic streptococcal carriage 2, 4
- Alternative regimens include amoxicillin-clavulanate or penicillin plus rifampin 2
Adjunctive Symptomatic Treatment
Acetaminophen or NSAIDs (ibuprofen) should be offered for moderate to severe symptoms or high fever with strong, high-quality evidence for reducing pain and inflammation. 2
Avoid aspirin in children due to the risk of Reye syndrome. 2
Corticosteroids are NOT recommended as adjunctive therapy for streptococcal pharyngitis. 2
Special Population: Pregnant Women (Group B Streptococcus Prophylaxis)
For intrapartum antibiotic prophylaxis in penicillin-allergic pregnant women: